Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute
Open Access
- 1 August 2001
- journal article
- Published by Elsevier BV in Annals of Oncology
- Vol. 12 (8), 1145-1150
- https://doi.org/10.1023/a:1011636912674
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcomaPublished by Elsevier BV ,1999
- Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.Journal of Clinical Oncology, 1998
- Osteogenic sarcoma of the extremity with detectable lung metastases at presentationCancer, 1997
- Osteogenic sarcoma with clinically detectable metastasis at initial presentation.Journal of Clinical Oncology, 1993
- A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.Journal of Clinical Oncology, 1992
- Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.Journal of Clinical Oncology, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Control of primary osteosarcoma with chemotherapyCancer, 1985
- The treatment of osteosarcoma of the extremities: Twenty year's experience at the istituto ortopedico rizzoliCancer, 1981
- Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgeryCancer, 1979